Story

TA 35 Surges 2.69% as Banking and Real Estate Stocks Lead Gains

ENTHMSVIIDZHZH-TWJAKOHI
Jul 15, 20261 min read
TA 35 Surges 2.69% as Banking and Real Estate Stocks Lead Gains

Summary

Israel's benchmark TA 35 index closed significantly higher on Wednesday, driven by a strong rally in the banking, financial, and real estate sectors. The advance marks a notable session for the Tel Aviv Stock Exchange.

Text size
Background

Israeli equities posted strong gains at the close of trading on Wednesday, with the benchmark TA 35 index advancing 2.69%. The rally was propelled by broad strength in the Banking, Financials, and Real Estate sectors, according to data from Investing.com.

Broad-Based Rally Lifts Tel Aviv Market

The positive sentiment was widespread across the Tel Aviv Stock Exchange, as evidenced by market breadth. Advancing stocks significantly outnumbered decliners by a margin of 326 to 155, while 78 stocks ended the session unchanged.

This broad-based rally pushed the main index to a strong finish, reflecting robust investor confidence in key domestic sectors during the trading day.

Sector Leaders and Laggards

Several companies recorded significant gains, leading the charge on the TA 35. The top performers for the session included:

Sample IUX Markets – In-articleAd
  • Mega Or (TASE:MGOR): Rose 6.46%
  • Next Vision Stabilized Systems (TASE:NXSN): Added 5.84%
  • Mizrahi Tefahot (TASE:MZTF): Climbed 5.64%

In contrast, a few component stocks bucked the upward trend. Elbit Systems Ltd (TASE:ESLT) fell by 0.70%, and Teva Pharmaceutical Industries Ltd (TASE:TEVA) registered a modest decline of 0.16%.

Currency and Commodity Markets

In the currency markets, the USD/ILS pair traded down 0.17% to 3.00. Meanwhile, commodity prices were generally lower. Brent oil futures for September delivery fell 1.25% to $83.67 a barrel, while August Gold Futures saw a minor decrease of 0.17% to trade at $4,062.72 per troy ounce.

Read next

More on Stocks
Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Stocks

Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Sep 20, 2026

Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) has resubmitted its application for a main board listing on the Hong Kong Stock Exchange, aiming to secure a dual listing to access international capital. The company specializes in drugs for central nervous system and cardiovascular diseases.

Back to latest news

LATEST